<DOC>
	<DOCNO>NCT00290212</DOCNO>
	<brief_summary>Study Objective : To determine whether Natto supplementation woman immediately menopause might prevent severe bone loss Study population : Women 50 - 60 year , 1-5 year menopause Study Design : Double-blind , placebo-controlled , randomize control trial . A `` phase II '' clinical trial . Instruments Used Measure Therapeutic Response : Lunar Prodigy DEXA bone densitometer Study Treatment Group : Daily supplementation Vitamin K2 , `` NATTO '' Study Control Group : Identically-looking placebo medication Duration treatment : 12 month Duration Subject Participation Study : 12 month Assessment Therapeutic response : Given expect reduction bone mass density - 1.1 % annually placebo group , minimum clinically significant difference group 0.3 percentage point . The trial therefore power detect reduction annual bone mass loss 0.3 percentage point treatment group . Numbers Evaluable Subjects Required : 304 Maximum # Subjects 334</brief_summary>
	<brief_title>Natto Supplementation Prevent Loss Bone Mass Women Immediately After Menopause</brief_title>
	<detailed_description />
	<criteria>Women live city Troms√∏ , use hormone replacement therapy , 15 year menopause . History hip fracture Bone disease affect bone mineral density Use vitamin K antagonists Significant comorbidity make difficult obtain BMD measurement Use hormone replacement therapy therapy influence bone remodeling</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Women</keyword>
	<keyword>Bone density</keyword>
	<keyword>Menopause</keyword>
	<keyword>Dietary Supplements</keyword>
	<keyword>Vitamin K2</keyword>
</DOC>